Literature DB >> 2503028

The pathophysiology of peri- and postmenopausal bone loss.

L Nilas1, C Christiansen.   

Abstract

Changes in sex hormones and bone turnover were studied longitudinally in 31 women aged 47-54 years who were approaching the menopause. Every 6 weeks for 2-3 years, hormones and biochemical estimates of the bone turnover were determined and the bone mass was measured at two forearm sites by single photon absorptiometry. Spinal bone mass was measured every 6 months. The bone turnover was normal in women aged 47-54 years with regular menstruation, whereas the estimates of bone resorption were high in the women with irregular menstruation. In nine women, who reached the menopause during the study, bone resorption increased significantly, whereas bone formation showed only a small increase. When the results of the nine women were combined with those of 50 women, who had passed a natural menopause within the preceding 3.5 years, the bone resorption indices reached their peak within the first postmenopausal year, whereas bone formation increased until 1.5-2 years after the last menstrual cycle. At the ultradistal forearm site the rate of bone loss was maximal (5% per year) immediately after the menopause and subsequently declined, which suggests that trabecular bone is more sensitive than cortical bone to changes in bone turnover. Spinal bone loss was identical in late peri- and early postmenopausal women. We conclude that bone resorption starts to increase during the last perimenopausal years, with a beginning acceleration in bone loss, which then becomes sharp after the menopause. The changes are related to the decline in oestrogens, but other mechanisms may also play a role.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2503028     DOI: 10.1111/j.1471-0528.1989.tb03260.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  14 in total

1.  Treatment of postmenopausal vertebral osteopenia with monofluorophospate: a long-term calcium-controlled study.

Authors:  M Gambacciani; A Spinetti; F Taponeco; L Piaggesi; B Cappagli; M Ciaponi; L C Rovati; A R Genazzani
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

2.  Potential value of urinary oestrogen assays in the identification of fast bone losers after the menopause.

Authors:  M H Walkinshaw; P A Mole; C R Paterson
Journal:  Osteoporos Int       Date:  1992-07       Impact factor: 4.507

Review 3.  Impact of bone mineral measurements on osteoporosis.

Authors:  I Fogelman; A Rodin; G Blake
Journal:  Eur J Nucl Med       Date:  1990

4.  The effect of the menopause and hormone replacement therapy on serum carboxyterminal propeptide of type I collagen.

Authors:  C Hassager; G Fabbri-Mabelli; C Christiansen
Journal:  Osteoporos Int       Date:  1993-01       Impact factor: 4.507

5.  Effect of hormone replacement therapy on markers of bone metabolism in RA.

Authors:  W F Lems; H R van den Brink; M I Gerrits; H J van Rijn; J W Bijlsma
Journal:  Ann Rheum Dis       Date:  1993-11       Impact factor: 19.103

6.  Early postmenopausal diminution of forearm and spinal bone mineral density: a cross-sectional study.

Authors:  K Bjarnason; C Hassager; P Ravn; C Christiansen
Journal:  Osteoporos Int       Date:  1995-01       Impact factor: 4.507

Review 7.  Tissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptoms.

Authors:  David F Archer
Journal:  Drugs Aging       Date:  2010-07-01       Impact factor: 3.923

8.  Overweight postmenopausal women lose bone with moderate weight reduction and 1 g/day calcium intake.

Authors:  Claudia S Riedt; Mariana Cifuentes; Theodore Stahl; Hasina A Chowdhury; Yvette Schlussel; Sue A Shapses
Journal:  J Bone Miner Res       Date:  2004-11-29       Impact factor: 6.741

9.  The effect of menopause on biochemical markers and ultrasound densitometry in healthy females.

Authors:  K Kawana; K Kushida; M Takahashi; T Ohishi; M Denda; K Yamazaki; T Inoue
Journal:  Calcif Tissue Int       Date:  1994-12       Impact factor: 4.333

10.  Osteoporosis and the Marfan syndrome.

Authors:  J R Gray; A B Bridges; P A Mole; T Pringle; M Boxer; C R Paterson
Journal:  Postgrad Med J       Date:  1993-05       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.